GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Axsome Therapeutics Inc (STU:19X) » Definitions » Cyclically Adjusted Book per Share

Axsome Therapeutics (STU:19X) Cyclically Adjusted Book per Share : €2.01 (As of Mar. 2025)


View and export this data going back to 2016. Start your Free Trial

What is Axsome Therapeutics Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Axsome Therapeutics's adjusted book value per share for the three months ended in Mar. 2025 was €1.000. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €2.01 for the trailing ten years ended in Mar. 2025.

During the past 12 months, Axsome Therapeutics's average Cyclically Adjusted Book Growth Rate was 5.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2025-05-28), Axsome Therapeutics's current stock price is €91.68. Axsome Therapeutics's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was €2.01. Axsome Therapeutics's Cyclically Adjusted PB Ratio of today is 45.61.

During the past 12 years, the highest Cyclically Adjusted PB Ratio of Axsome Therapeutics was 63.19. The lowest was 32.96. And the median was 42.18.


Axsome Therapeutics Cyclically Adjusted Book per Share Historical Data

The historical data trend for Axsome Therapeutics's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Axsome Therapeutics Cyclically Adjusted Book per Share Chart

Axsome Therapeutics Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 2.12

Axsome Therapeutics Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.94 1.96 1.90 2.12 2.01

Competitive Comparison of Axsome Therapeutics's Cyclically Adjusted Book per Share

For the Biotechnology subindustry, Axsome Therapeutics's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Axsome Therapeutics's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Axsome Therapeutics's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Axsome Therapeutics's Cyclically Adjusted PB Ratio falls into.


;
;

Axsome Therapeutics Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Axsome Therapeutics's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book= Book Value per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=1/134.9266*134.9266
=1.000

Current CPI (Mar. 2025) = 134.9266.

Axsome Therapeutics Quarterly Data

Book Value per Share CPI Adj_Book
201506 -0.363 100.684 -0.486
201509 0.196 100.392 0.263
201512 2.227 99.792 3.011
201603 1.934 100.470 2.597
201606 1.622 101.688 2.152
201609 1.311 101.861 1.737
201612 1.067 101.863 1.413
201703 1.163 102.862 1.526
201706 0.858 103.349 1.120
201709 0.597 104.136 0.774
201712 0.554 104.011 0.719
201803 0.399 105.290 0.511
201806 0.229 106.317 0.291
201809 0.024 106.507 0.030
201812 0.027 105.998 0.034
201903 0.462 107.251 0.581
201906 0.626 108.070 0.782
201909 0.180 108.329 0.224
201912 4.355 108.420 5.420
202003 3.812 108.902 4.723
202006 3.675 108.767 4.559
202009 3.075 109.815 3.778
202012 2.503 109.897 3.073
202103 2.153 111.754 2.599
202106 1.575 114.631 1.854
202109 0.963 115.734 1.123
202112 0.366 117.630 0.420
202203 0.343 121.301 0.382
202206 0.360 125.017 0.389
202209 3.660 125.227 3.944
202212 2.378 125.222 2.562
202303 2.398 127.348 2.541
202306 5.525 128.729 5.791
202309 5.337 129.860 5.545
202312 3.698 129.419 3.855
202403 2.792 131.776 2.859
202406 1.999 132.554 2.035
202409 1.728 133.029 1.753
202412 1.119 133.157 1.134
202503 1.000 134.927 1.000

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Axsome Therapeutics  (STU:19X) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Axsome Therapeutics's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=91.68/2.01
=45.61

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 12 years, the highest Cyclically Adjusted PB Ratio of Axsome Therapeutics was 63.19. The lowest was 32.96. And the median was 42.18.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Axsome Therapeutics Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Axsome Therapeutics's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Axsome Therapeutics Business Description

Industry
Traded in Other Exchanges
Address
One World Trade Center, 22nd Floor, New York, NY, USA, 10007
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.

Axsome Therapeutics Headlines

No Headlines